|
Mar, 2010 | Pages : 25 | Price : US$ 0.00 |
|
| |
|
Mar, 2010 | Pages : 75 | Price : US$ 0.00 |
|
| |
|
Jan, 2010 | Pages : 40 | Price : US$ 800.00 |
| Although the market is currently dominated by local and unorganized players, the organized segment has also reported strong growth. The services are projected to grow at a CAGR of more than 20%. |
| |
|
Jan, 2010 | Pages : 85 | Price : US$ 1000.00 |
| It is expected that Indian healthcare market will grow at a CAGR of around 21% during 2010-2013. |
| |
|
Dec, 2009 | Pages : 45 | Price : US$ 1000.00 |
| With continuous increase in demand, the industry is expected to witness growth of around 8% in 2009 over the previous year. |
| |
|
Dec, 2009 | Pages : 130 | Price : US$ 1500.00 |
| The pharmaceutical market in the above mentioned emerging countries is projected to grow at a CAGR of around 14.7% during 2009-2012. |
| |
|
Dec, 2009 | Pages : 105 | Price : US$ 1600.00 |
| The global IVD market is forecast to grow at a CAGR of around 9% during 2010-2012. The market is particularly characterized by the emergence of various novel technologies. |
| |
|
Dec, 2009 | Pages : 170 | Price : US$ 1800.00 |
| The global pharma industry is projected to grow at a CAGR of around 6% during 2010-2012. The growth will be driven by low cost factor. |
| |
|
Nov, 2009 | Pages : 100 | Price : US$ 1200.00 |
| The future of pharma industry in the Asia-Pacific region remains bright, and the industry is projected to grow at a CAGR of around 12.6% during 2010-2012. |
| |
|
Nov, 2009 | Pages : 55 | Price : US$ 1100.00 |
| The biotech market in Malaysia is expected to grow at a CAGR of around 21% during 2010-2012. |
| |
|
|
